Tandem Diabetes Care (TNDM) Competitors $30.15 +2.28 (+8.18%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends TNDM vs. IART, IRTC, NVRO, ICUI, HAE, BLCO, INSP, PRCT, AXNX, and NVSTShould you be buying Tandem Diabetes Care stock or one of its competitors? The main competitors of Tandem Diabetes Care include Integra LifeSciences (IART), iRhythm Technologies (IRTC), Nevro (NVRO), ICU Medical (ICUI), Haemonetics (HAE), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Axonics (AXNX), and Envista (NVST). These companies are all part of the "medical" sector. Tandem Diabetes Care vs. Integra LifeSciences iRhythm Technologies Nevro ICU Medical Haemonetics Bausch + Lomb Inspire Medical Systems PROCEPT BioRobotics Axonics Envista Integra LifeSciences (NASDAQ:IART) and Tandem Diabetes Care (NASDAQ:TNDM) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations, community ranking, dividends and media sentiment. Which has more volatility and risk, IART or TNDM? Integra LifeSciences has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Comparatively, Tandem Diabetes Care has a beta of 1.36, indicating that its stock price is 36% more volatile than the S&P 500. Which has higher earnings & valuation, IART or TNDM? Integra LifeSciences has higher revenue and earnings than Tandem Diabetes Care. Integra LifeSciences is trading at a lower price-to-earnings ratio than Tandem Diabetes Care, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIntegra LifeSciences$1.56B1.13$67.74M-$0.09-254.78Tandem Diabetes Care$854.35M2.32-$222.61M-$1.93-15.62 Is IART or TNDM more profitable? Integra LifeSciences has a net margin of -0.42% compared to Tandem Diabetes Care's net margin of -14.84%. Integra LifeSciences' return on equity of 12.35% beat Tandem Diabetes Care's return on equity.Company Net Margins Return on Equity Return on Assets Integra LifeSciences-0.42% 12.35% 4.82% Tandem Diabetes Care -14.84%-44.19%-11.99% Do analysts prefer IART or TNDM? Integra LifeSciences presently has a consensus price target of $24.00, suggesting a potential upside of 4.67%. Tandem Diabetes Care has a consensus price target of $54.25, suggesting a potential upside of 79.93%. Given Tandem Diabetes Care's stronger consensus rating and higher possible upside, analysts plainly believe Tandem Diabetes Care is more favorable than Integra LifeSciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Integra LifeSciences 3 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.75Tandem Diabetes Care 0 Sell rating(s) 4 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.78 Does the MarketBeat Community favor IART or TNDM? Tandem Diabetes Care received 145 more outperform votes than Integra LifeSciences when rated by MarketBeat users. Likewise, 61.20% of users gave Tandem Diabetes Care an outperform vote while only 56.90% of users gave Integra LifeSciences an outperform vote. CompanyUnderperformOutperformIntegra LifeSciencesOutperform Votes43756.90% Underperform Votes33143.10% Tandem Diabetes CareOutperform Votes58261.20% Underperform Votes36938.80% Does the media favor IART or TNDM? In the previous week, Tandem Diabetes Care had 6 more articles in the media than Integra LifeSciences. MarketBeat recorded 9 mentions for Tandem Diabetes Care and 3 mentions for Integra LifeSciences. Tandem Diabetes Care's average media sentiment score of 1.34 beat Integra LifeSciences' score of 1.24 indicating that Tandem Diabetes Care is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integra LifeSciences 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tandem Diabetes Care 8 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in IART or TNDM? 84.8% of Integra LifeSciences shares are held by institutional investors. 3.1% of Integra LifeSciences shares are held by insiders. Comparatively, 2.2% of Tandem Diabetes Care shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryTandem Diabetes Care beats Integra LifeSciences on 10 of the 18 factors compared between the two stocks. Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. Get Tandem Diabetes Care News Delivered to You Automatically Sign up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNDM vs. The Competition Export to ExcelMetricTandem Diabetes CareSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.83B$4.41B$5.03B$8.81BDividend YieldN/A41.16%5.16%4.06%P/E Ratio-15.6224.82135.4117.82Price / Sales2.3247.021,160.9774.56Price / CashN/A51.8733.5332.53Price / Book6.274.974.674.68Net Income-$222.61M$13.76M$119.07M$226.08M7 Day Performance5.46%-1.08%-1.83%-1.04%1 Month Performance-11.61%0.58%-3.60%1.04%1 Year Performance63.77%50.91%31.66%26.28% Tandem Diabetes Care Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNDMTandem Diabetes Care4.7486 of 5 stars$30.15+8.2%$54.25+79.9%+63.7%$1.83B$747.72M-15.622,400Positive NewsIARTIntegra LifeSciences2.7938 of 5 stars$22.93+0.2%$24.00+4.7%-40.7%$1.77B$1.54B0.003,946Positive NewsIRTCiRhythm Technologies3.2268 of 5 stars$73.74-2.3%$108.50+47.1%-11.8%$2.36B$492.68M0.002,000NVRONevro2.8885 of 5 stars$4.23-0.2%$9.10+115.1%-74.5%$158.88M$425.17M0.001,215Analyst UpgradeGap DownICUIICU Medical4.0342 of 5 stars$167.59-1.2%$173.00+3.2%+94.1%$4.15B$2.26B0.0014,000Analyst UpgradeShort Interest ↓HAEHaemonetics4.925 of 5 stars$84.92+0.1%$107.88+27.0%+2.4%$4.26B$1.31B35.243,657BLCOBausch + Lomb2.7887 of 5 stars$19.39-0.8%$20.91+7.8%+23.2%$6.83B$4.68B-18.4713,300INSPInspire Medical Systems4.91 of 5 stars$184.88+5.0%$233.58+26.3%+29.2%$5.28B$624.80M172.781,011Analyst UpgradePositive NewsGap UpPRCTPROCEPT BioRobotics1.5836 of 5 stars$92.70-0.9%$89.50-3.5%+180.7%$4.88B$136.19M0.00626AXNXAxonics3.2587 of 5 stars$70.98flat$71.00+0.0%N/A$3.63B$366.38M-591.45610News CoverageNVSTEnvista3.6426 of 5 stars$20.37+0.5%$20.71+1.7%-14.3%$3.49B$2.57B0.0012,800 Related Companies and Tools Related Companies IART Alternatives IRTC Alternatives NVRO Alternatives ICUI Alternatives HAE Alternatives BLCO Alternatives INSP Alternatives PRCT Alternatives AXNX Alternatives NVST Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TNDM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tandem Diabetes Care, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tandem Diabetes Care With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TNDM Stock Alerts